NCT01407770 2023-03-28
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Wake Forest University Health Sciences
Completed
Clinical Trials
10 trialsNCT00003857 2022-05-25
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00599989 2020-04-09
Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT00373191 2015-10-12
Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
NCT01008514 2015-03-26
Partial-Breast Radiation Therapy in Treating Women With Early-Stage Breast Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Withdrawn
NCT00602628 2013-06-26
Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast
National Cancer Institute (NCI)
Phase NA Completed
NCT00354640 2013-06-24
Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00244959 2013-03-19
Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00002920 2012-10-31
S9630, Medroxyprogesterone in Treating Women With Breast Cancer
SWOG Cancer Research Network
Phase 3 Completed
NCT00077168 2009-02-09
Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
National Cancer Institute (NCI)
Phase 2 Unknown